Is cardiovascular disease in patients with diabetes associated with serum levels of MMP-2, LOX, and the elastin degradation products ELM and ELM-2?

about

No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients.

P2860

Q55071518-C9B8813B-034C-4CD3-A222-04A13C3B18CC

P2860

Is cardiovascular disease in patients with diabetes associated with serum levels of MMP-2, LOX, and the elastin degradation products ELM and ELM-2?

Item

http://www.wikidata.org/entity/Q48114716

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Is cardiovascular disease in p ...... dation products ELM and ELM-2?

@en

Is cardiovascular disease in p ...... dation products ELM and ELM-2?

@nl

type

Item

label

Is cardiovascular disease in p ...... dation products ELM and ELM-2?

@en

Is cardiovascular disease in p ...... dation products ELM and ELM-2?

@nl

prefLabel

Is cardiovascular disease in p ...... dation products ELM and ELM-2?

@en

Is cardiovascular disease in p ...... dation products ELM and ELM-2?

@nl

P1476

Is cardiovascular disease in p ...... dation products ELM and ELM-2?

@en

P2093

Diana Julie Leeming

http://www.w3.org/2001/XMLSchema#string

Mikael Kjær Poulsen

http://www.w3.org/2001/XMLSchema#string

Simone Andrea Rørdam Preil

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressure

Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation.

High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.

Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAs

Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus.

Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.

Lysyl oxidase: an oxidative enzyme and effector of cell function.

Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes.

Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development.

P304

493-497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00365513.2017.1346822

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lars M Rasmussen

Anne L Christiansen

Anne-Sofie Allermann Faarvang

Morten Asser Karsdal

P577

2017-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28715234

http://www.w3.org/2001/XMLSchema#string

Is cardiovascular disease in patients with diabetes associated with serum levels of MMP-2, LOX, and the elastin degradation products ELM and ELM-2?

about

P2860

P2860

Is cardiovascular disease in patients with diabetes associated with serum levels of MMP-2, LOX, and the elastin degradation products ELM and ELM-2?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698